Literature DB >> 15558227

[Whole-body MRI and PET/CT in tumor diagnosis].

G P Schmidt1, R Schmid, K Hahn, M F Reiser.   

Abstract

Tumor staging according to the TNM-system influences prognosis and therapeutical options of patients with a malignant disease. It is the challenge of diagnostic imaging to depict the exact localization of the primary tumor and to detect or rule out lymph node involvement or distant metastases. In doing so, the complete body anatomy should be covered with a modality that offers high sensitivity and specificity. As these requirements could not or only partially be achieved by previous ordinary procedures, the use of multiple different modalities became necessary. Last but not least, in consideration of the costs it would be preferable to replace this cascade of different modalities by a "whole body examination", preconditioned that the same accuracy is achieved.With PET/CT and whole-body MRI, two newly available promising methods for a systemic tumor staging have been developed. First experiences indicate PET/CT as a method of first choice. With the introduction of new whole-body MRI scanners using parallel imaging technique (iPAT) and free table movement, MRI plays a more and more important role in whole body tumor staging.

Entities:  

Mesh:

Year:  2004        PMID: 15558227     DOI: 10.1007/s00117-004-1128-3

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  33 in total

1.  Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients.

Authors:  G S Mijnhout; O S Hoekstra; M W van Tulder; G J Teule; W L Devillé
Journal:  Cancer       Date:  2001-04-15       Impact factor: 6.860

2.  [Whole-body MRA on a rolling table platform (AngioSURF)].

Authors:  S G Ruehm; M Goyen; H H Quick; M Schlepütz; H Schlepütz; S Bosk; J Barkhausen; M E Ladd; J F Debatin
Journal:  Rofo       Date:  2000-08

3.  Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography--initial experience.

Authors:  Mathias Goyen; Christoph U Herborn; Knut Kröger; Thomas C Lauenstein; Jörg F Debatin; Stefan G Ruehm
Journal:  Radiology       Date:  2003-02-19       Impact factor: 11.105

4.  Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients.

Authors:  Medhat M Osman; Christian Cohade; Yuji Nakamoto; Laura T Marshall; Jeff P Leal; Richard L Wahl
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

5.  Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging.

Authors:  G Hargaden; M O'Connell; E Kavanagh; T Powell; R Ward; S Eustace
Journal:  AJR Am J Roentgenol       Date:  2003-01       Impact factor: 3.959

6.  Total-body echo-planar MR imaging in the staging of breast cancer: comparison with conventional methods--early experience.

Authors:  L J Horvath; B A Burtness; S McCarthy; K M Johnson
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

7.  Whole-body MRI using a rolling table platform for the detection of bone metastases.

Authors:  Thomas C Lauenstein; Lutz S Freudenberg; Susanne C Goehde; Stefan G Ruehm; Mathias Goyen; Silke Bosk; Jörg F Debatin; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2002-03-08       Impact factor: 5.315

8.  "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity.

Authors:  R L Wahl; L E Quint; R D Cieslak; A M Aisen; R A Koeppe; C R Meyer
Journal:  J Nucl Med       Date:  1993-07       Impact factor: 10.057

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

View more
  1 in total

Review 1.  [Automated procedure for volumetric measurement of metastases: estimation of tumor burden].

Authors:  M Fabel; H Bolte
Journal:  Radiologe       Date:  2008-09       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.